Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004091 · ClinicalTrials.gov registry record
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 100
- Enrollment target
NCT00004091 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 100 participants.
The verdict
NCT00004091 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Examining biomarkers in abnormal cervical cells may improve the ability to detect these cells and plan effective treatment. PURPOSE: Diagnostic trial to detect specific biomarkers in abnormal cervical cells in women who have abnormal Pap test results.
Interventions
- OTHER cytology specimen collection procedure
- PROCEDURE study of high risk factors
- OTHER Papanicolaou test
- OTHER fluorescent antibody technique
- PROCEDURE colposcopic biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 1999-08 |
| Est. Completion | 2001-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004091
The ClinicalTrials.gov registry entry for NCT00004091 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cytology specimen collection procedure is the first listed.
NCT00004091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004091 about?
NCT00004091 is a clinical study titled "Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results". RATIONALE: Examining biomarkers in abnormal cervical cells may improve the ability to detect these cells and plan effective treatment. PURPOSE: Diagnostic trial to detect specific biomarkers in abnormal cervical cells in women who have abnormal Pap test results.
What is the current status of trial NCT00004091?
This trial is currently completed. The enrollment target is 100 participants. The study started on 1999-08. Estimated completion is 2001-02.
What interventions are being tested in trial NCT00004091?
The interventions under investigation include: cytology specimen collection procedure (OTHER), study of high risk factors (PROCEDURE), Papanicolaou test (OTHER), fluorescent antibody technique (OTHER), colposcopic biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00004091?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.